Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
HCA Healthcare ( (HCA) ) has issued an announcement.
On July 8, 2025, HCA Healthcare announced the appointment of John W. Chidsey, III to its Board of Directors, effective July 15, 2025, expanding the board from nine to ten members. Chidsey, with a distinguished career including leadership roles at Subway and Burger King, will serve on several key committees, bringing valuable financial and operational expertise to HCA Healthcare. This strategic appointment is expected to bolster the company’s commitment to improving healthcare delivery and patient outcomes.
The most recent analyst rating on (HCA) stock is a Buy with a $425.00 price target. To see the full list of analyst forecasts on HCA Healthcare stock, see the HCA Stock Forecast page.
Spark’s Take on HCA Stock
According to Spark, TipRanks’ AI Analyst, HCA is a Outperform.
HCA Healthcare’s strong financial performance and positive technical indicators drive a high score. Robust earnings growth and effective cost management highlight operational strength, despite concerns over leverage and valuation constraints.
To see Spark’s full report on HCA stock, click here.
More about HCA Healthcare
Nashville-based HCA Healthcare is one of the nation’s leading providers of healthcare services, operating 192 hospitals and approximately 2,500 ambulatory sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics in 20 states and the United Kingdom. Founded in 1968, HCA Healthcare pioneered a model for hospital care in the United States, focusing on patient-centered care and medical practice improvement. The company is a learning health system that leverages its 44 million annual patient encounters to advance science, enhance patient care, and save lives.
Average Trading Volume: 1,473,295
Technical Sentiment Signal: Strong Buy
Current Market Cap: $91.04B
See more data about HCA stock on TipRanks’ Stock Analysis page.